The so-called Santa Claus Rally reflects the tendency of stocks to rally higher around the Christmas holidays... but is this phenomenon just fiction or...
Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative...
Newly issued patent expected to provide protection until at least 2041 and includes composition of matter claims to pharmaceutical compositions within...
This year's Wonderland Conference in Miami provided inspiring and sometimes hilarious insights into the integration process of psychedelics entering mainstream...
Potentially groundbreaking results as Cybin's Phase 2 Study of CYB003 in Major Depressive Disorder showed 79% of patients in remission after two 12mg doses. The...
Terran’s new patents cover new psilocybin forms, orally active DMT, and 5-MeO-DMT, and novel forms of ibogaine derivative tabernanthalog. The post Terran...
New patent provides IP protection until at least 2041. Cybin’s patent portfolio now includes 39 granted patents and over 170 pending applications. The...
A bipartisan group of congressional lawmakers from both the House and the Senate have added funding for studies of psychedelic therapies into a major defense...
In the past few years, psychedelics have been attracting a lot more public debate and positive coverage. The so-called psychedelic renaissance has made...
Some peace activists and researchers believe the powerful psychedelic can help build mutual reconciliation between the two communities.